All In Biotech

Drug Trial Radar · NCT06454188

A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis

A Randomized, Placebo-controlled, Multicenter, Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis (UP-SPOUT)

Last checked: Nov 20, 2026Latest source record: Apr 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 100 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

100

Planned (sponsor's estimate)

Start

Dec 3, 2024

Primary completion

Sep 2028

Study completion Oct 2028

Sponsor

Lead sponsor
CARE ARTHRITIS LTD.Industry
Sponsor type
Industry
Collaborators
AbbVie
First posted
Jun 12, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Randomized, Placebo-controlled, Multicenter, Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients with Active Psoriatic Arthritis (UP-SPOUT)

Conditions

  • Psoriatic Arthritis
  • Spondyloarthritis, Axial

Interventions

  • Upadacitinib 15 MG [Rinvoq]Drug

    15mg tablet once per day.

  • PlaceboDrug

    15mg tablet once per day.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline in the (SPARCC) MRI inflammation score (for SIJ and spine) at 12 weeks of therapy with upadacitinib vs placebo in the DMARD-IR (conventional and/or biologic) subgroupTime frame: 12 weeks

Locations

5 sites in 2 countries. Site status is shown where the registry gives one.

  • University Hospitals Cleveland Medical Center

    Cleveland, Ohio · Recruiting

  • Oregon Health and Science University

    Portland, Oregon · Recruiting

  • University of Pennsylvania

    Philadelphia, Pennsylvania · Recruiting

  • The Ottawa Hospital Research Institute

    Ottawa, Ontario, Canada · Recruiting

  • Groupe de Recherche en Maladies Osseuses (G.R.M.O.) Inc.

    Québec, Quebec, Canada · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.